 |
|
|
| |
Effects of the siRNA JNJ-3989 and/or the Capsid Assembly
Modulator JNJ-6379 on Viral Markers of Chronic Hepatitis B:
Results From the REEF-1 Study
|
| |
| |
EASL 2022 June 22-26 London
Man-Fung Yuen,1,* Tarik Asselah,2 Ira M. Jacobson,3 Maurizia Brunetto,4 Harry L.A. Janssen,5 Tetsuo Takehara,6 Jin Lin Hou,7 Thomas N. Kakuda,8 Tom Lambrecht,9
Ronald Kalmeijer,10 Carine Guinard-Azadian,9 Cristiana Mayer,10 John Jezorwski,10 Thierry Verbinnen,9 Oliver Lenz,9 Umesh Shukla,10 Michael Biermer9
1Department of Medicine & State Key Laboratory of Liver Research, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China; 2Université de Paris, INSERM UMR1149 and Hôpital Beaujon, APHP, Clichy, France; 3New York University Grossman School of Medicine, New York, NY, USA; 4University of Pisa, Pisa, Italy; 5University of Toronto, Toronto, Canada; 6Osaka University Graduate School of Medicine, Osaka, Japan; 7Nanfang Hospital, Southern Medical University, Guangzhou, China; 8Janssen Research & Development, LLC, South San Francisco, CA, USA; 9Janssen Research & Development, Beerse, Belgium; 10Janssen Research & Development, LLC, Titusville, NJ, USA.
|
| |
|
|
|
|
|
